
(AGENPARL) – SILVER SPRING gio 20 aprile 2023 FDA will provide an overview of the current status and the gaps related to the inclusion of neonates in drug development.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/overview-clinical-pharmacology-considerations-neonatal-studies-02152023